These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2900131)

  • 1. Systemic and regional haemodynamic profile of diuretics and alpha- and beta-blockers. A review comparing acute and chronic effects.
    Mimran A; Ducailar G
    Drugs; 1988; 35 Suppl 6():60-9. PubMed ID: 2900131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect.
    Lund-Johansen P; Omvik P
    Cardiovasc Drugs Ther; 1991 Jun; 5(3):605-15. PubMed ID: 1678963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ; McNeil JJ; Drummer OH
    Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of drugs in countering adverse pathophysiological profiles: influence on hemodynamics.
    Lund-Johansen P
    Am Heart J; 1987 Oct; 114(4 Pt 2):958-64. PubMed ID: 2889344
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha-Methyldopa and beta-blockers in hypertension--a comparison of their haemodynamic effects.
    Lund-Johansen P
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():23-34. PubMed ID: 28190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension.
    Lund-Johansen P
    Clin Nephrol; 1992; 38 Suppl 1():S78-86. PubMed ID: 1363538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic and renal hemodynamic effects of a new alpha-adrenergic blocking agent: NC 7197.
    Lohmöller RM; Lohmöller GJ; Frohlich ED
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):170-80. PubMed ID: 4147750
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise.
    Koch G
    Br J Clin Pharmacol; 1979; 8(Suppl 2):101S-105S. PubMed ID: 43162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial hypoxemia in awake dogs. Role of the sympathetic nervous system in mediating the systemic hemodynamic and regional blood flow responses.
    Doherty JU; Liang CS
    J Lab Clin Med; 1984 Nov; 104(5):665-77. PubMed ID: 6149249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic effects of alpha-receptor blockade during acute administration and chronic treatment.
    Rasmussen K
    Acta Med Scand Suppl; 1982; 665():83-5. PubMed ID: 6130679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal haemodynamics in hypertension: effects of antihypertensive drugs.
    Dupont AG
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S42-5. PubMed ID: 8487249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenergic blockade and renal hemodynamics.
    McCombs PR; Berkowitz HD
    Surgery; 1976 Aug; 80(2):246-251. PubMed ID: 7845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of the pharmacodynamic properties and therapeutic potential of combined alpha- and beta-adrenoceptor antagonists.
    van Zwieten PA
    Drugs; 1993 Apr; 45(4):509-17. PubMed ID: 7684671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional blood flow distribution during the Cushing response: alterations with adrenergic blockade.
    van Wylen DG; D'Alecy LG
    Am J Physiol; 1985 Jan; 248(1 Pt 2):H98-108. PubMed ID: 2857527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R; Koulu M; Allonen H
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of proxodolol on systemic and regional hemodynamics].
    Dolgun OV; Martynova ER; Medvedev OS; Iuzhakov SD
    Eksp Klin Farmakol; 1994; 57(3):33-6. PubMed ID: 7914116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenergic and non-adrenergic cardiovascular effects of thyrotropin-releasing hormone (TRH) in the anaesthetized rabbit.
    Seligsohn EE
    Acta Physiol Scand; 1992 Sep; 146(1):107-17. PubMed ID: 1359733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha- and beta-receptor blocking drugs in the treatment of hypertension.
    Ram CV; Kaplan NM
    Curr Probl Cardiol; 1979 Jan; 3(10):1-53. PubMed ID: 40755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.